Genworth Earnings Call: Enact Strength, LTC Drag

Genworth Financial Inc ((GNW)) has held its Q1 earnings call. Read on for the main highlights of the call.

Genworth Financial’s latest earnings call struck a cautiously upbeat tone, as strong operating results from Enact and rapid scaling at CareScout overshadowed accounting noise and liquidity questions tied to the legacy long‑term care block. Management leaned into a story of steady capital returns and disciplined risk reduction, arguing that fundamental cash economics remain stronger than volatile GAAP figures suggest.

Consolidated Profitability and Core Operating Income

Genworth reported Q1 2026 net income of $47 million, with consolidated adjusted operating income of $109 million when excluding the closed block. Enact remained the engine, delivering $140 million in adjusted operating income, boosted by a $39 million pretax reserve release that helped drive a notably low 15% loss ratio.

Enact Capital Returns and Share Repurchases

Capital return from Enact is ramping up, with $99 million received in Q1 and about $500 million expected for full‑year 2026, of which Genworth should capture roughly $405–450 million based on its 81% stake. Management raised 2026 share repurchase guidance to $195–225 million after buying back $66 million of stock in Q1 at $8.61 per share plus another $19 million through late April, bringing cumulative buybacks to $875 million.

CareScout Scaling and Revenue Trajectory

CareScout is emerging as Genworth’s growth platform, facilitating about 1,500 matches in Q1 and targeting around 7,500 matches in 2026, more than doubling 2025 volumes. Services revenue reached $6 million in the quarter toward a $25 million full‑year goal, supported by a broad network that already covers roughly 97% of the U.S. 65+ population for home care and planned 2026 investments of $50–55 million.

Closed Block Long‑Term Remediation Progress (MYRAP)

The multiyear rate action plan continues to chip away at long‑term care risks, with Genworth estimating about $34.5 billion in net present value created since 2012 through premium hikes and benefit reductions. Q1 saw $5 million of gross premium approvals, with another $45 million already secured in Q2, and management expects MYRAP to add roughly $1 billion of economic value in 2026, broadly in line with 2025.

Reduced Exposure to Highest‑Risk LTC Features

Risk in the long‑term care block is gradually being de‑risked as policy features are restructured away from the most generous benefits. Exposure to 5% compound inflation options has fallen to below 36% from 57% in 2014, while lifetime benefit policies are down to about 11% and roughly 61% of policyholders offered benefit reductions have accepted them.

Conservative Investment Position and Attractive Yields

Genworth highlighted a largely investment‑grade portfolio designed to match long‑duration liabilities while taking advantage of higher rates, with new‑money yields in the life companies near 6.3% in Q1. Alternative assets are targeted to return around 12%, and exposure to riskier middle‑market loans remains modest at about 1%, with private placements primarily investment‑grade.

Improved Capital Allocation Framework and Guidance

To sharpen focus on core value creation, Genworth is now reporting consolidated adjusted operating income excluding the closed block, aligning metrics with its strategic priorities in Enact and CareScout. Capital allocation remains anchored on funding CareScout growth, returning capital through buybacks, and opportunistically reducing debt, supported by a holding‑company cash interest coverage ratio of roughly 9 times.

Closed Block GAAP Volatility and Quarterly Loss

The closed block continued to weigh on reported results, posting a Q1 adjusted operating loss of $32 million driven largely by a $36 million pretax assumption‑to‑experience loss, mainly in long‑term care. Management cautioned that A‑to‑E losses are expected to total about $300 million for full‑year 2026, emphasizing that these GAAP swings reflect accounting remeasurements rather than underlying cash flows.

Holding Company Liquidity and Leverage Considerations

At the holding company, Genworth ended Q1 with $166 million in cash and liquid assets, excluding roughly $50 million reserved for future obligations, against $778 million of debt after a small principal paydown. While debt service coverage looks solid, management acknowledged that the cash balance is relatively modest versus near‑term needs, making disciplined capital deployment and Enact dividends critical.

Enact Book Value and Premium Pressures

Despite strong profitability, Enact is seeing some pressure on reported metrics, with Genworth’s share of book value including AOCI edging down to $4.3 billion from $4.4 billion due mainly to higher‑rate‑driven market value moves. Earned premiums declined slightly year over year to $243 million and new insurance written of $13 billion was seasonally lower, though the business still benefits from a large $272 billion insurance‑in‑force base.

Mortality, Reserve and Statutory Pressures

Seasonally higher mortality in the quarter pushed up reserves in both long‑term care and life, adding to volatility in the closed block and prompting some reserve builds on the life side. GLIC’s estimated RBC ratio dipped to 2.89, but management stressed it remains above regulatory minimums and within internal targets, framing the impact as manageable rather than systemic.

Quarterly GAAP Losses Not Reflective of Cash Economics

Executives repeatedly argued that quarterly GAAP losses tied to assumption updates and reserve changes in the closed block obscure the economic reality of improving cash flows from remediation. Investors were urged to focus on capital generation from Enact and the growing fee‑based trajectory at CareScout as better indicators of underlying value than headline GAAP volatility.

Forward‑Looking Guidance and Strategic Outlook

Looking ahead, Genworth reaffirmed 2026 targets across its businesses, anchored by roughly $500 million of capital returns from Enact, $195–225 million earmarked for share buybacks, and continued expansion at CareScout toward about 7,500 matches and $25 million in 2026 services revenue. The company plans to invest $50–55 million in CareScout services this year, while expecting ongoing MYRAP actions to deliver around $1 billion in economic value and keeping life company new‑money yields near current attractive levels.

Genworth’s earnings call painted the picture of a company steadily extracting value from its mortgage insurance franchise and nurturing a growing services platform, even as legacy long‑term care continues to distort GAAP results and constrain liquidity. For investors, the key takeaway is a balance between robust capital return potential and ongoing closed‑block risk, with management betting that disciplined execution will allow operational momentum to win out over accounting noise.